(S)-N-(4-Methyl-3-(1-methyl-2-oxo-7-(pyrrolidin-3-yloxy)-1,2-dihydropyrimido[4,5-d]pyrimidin-3(4H)-yl)phenyl)-3-(trifluoromethyl)benzamide

ID: ALA3780177

Chembl Id: CHEMBL3780177

PubChem CID: 127031370

Max Phase: Preclinical

Molecular Formula: C26H25F3N6O3

Molecular Weight: 526.52

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(O[C@H]3CCNC3)nc2N(C)C1=O

Standard InChI:  InChI=1S/C26H25F3N6O3/c1-15-6-7-19(32-23(36)16-4-3-5-18(10-16)26(27,28)29)11-21(15)35-14-17-12-31-24(38-20-8-9-30-13-20)33-22(17)34(2)25(35)37/h3-7,10-12,20,30H,8-9,13-14H2,1-2H3,(H,32,36)/t20-/m0/s1

Standard InChI Key:  FRSATDYAMPIXKE-FQEVSTJZSA-N

Alternative Forms

  1. Parent:

    ALA3780177

    ---

Associated Targets(Human)

K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Bcr/Abl fusion protein (1667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Transcription factor ETV6/Tyrosine-protein kinase ABL1 (41 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 526.52Molecular Weight (Monoisotopic): 526.1940AlogP: 4.37#Rotatable Bonds: 5
Polar Surface Area: 99.69Molecular Species: BASEHBA: 6HBD: 2
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 10.11CX LogP: 3.86CX LogD: 1.26
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.51Np Likeness Score: -1.30

References

1. Liang X, Liu X, Wang B, Zou F, Wang A, Qi S, Chen C, Zhao Z, Wang W, Qi Z, Lv F, Hu Z, Wang L, Zhang S, Liu Q, Liu J..  (2016)  Discovery of 2-((3-Amino-4-methylphenyl)amino)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)-4-(methylamino)pyrimidine-5-carboxamide (CHMFL-ABL-053) as a Potent, Selective, and Orally Available BCR-ABL/SRC/p38 Kinase Inhibitor for Chronic Myeloid Leukemia.,  59  (5): [PMID:26789553] [10.1021/acs.jmedchem.5b01618]

Source